【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 14
1.2 List of Figures 18
2 Introduction 20
2.1 Catalyst 20
2.2 Related Reports 20
3 Disease Overview 21
3.1 Etiology and Pathophysiology 21
3.1.1 Etiology 21
3.1.2 Pathophysiology 22
3.2 Classification 22
3.3 Symptoms 23
3.4 Prognosis 23
3.5 Quality of Life 24
4 Epidemiology 25
4.1 Disease Background 25
4.2 Risk Factors and Comorbidities 26
4.3 Global Trends 27
4.3.1 US 29
4.3.2 5EU 31
4.3.3 Japan 31
4.4 Forecast Methodology 32
4.4.1 Sources Used 32
4.4.2 Sources Not Used 38
4.4.3 Forecast Assumptions and Methods – Total Prevalent Cases of IBS 39
4.4.4 Forecast Assumptions and Methods – IBS Subtype Segmentations 42
4.5 Epidemiological Forecast for IBS (2013-2023) 44
4.5.1 Total Prevalent Cases of IBS 44
4.5.2 Age-Specific Total Prevalent Cases of IBS 46
4.5.3 Sex-Specific Total Prevalent Cases of IBS 48
4.5.4 Age-Standardized Total Prevalence of IBS 50
4.5.5 Total Prevalent Cases of IBS by Clinical Subtype 51
4.6 Discussion 53
4.6.1 Epidemiological Forecast Insight 53
4.6.2 Limitations of the Analysis 54
4.6.3 Strengths of the Analysis 56
5 Disease Management 57
5.1 Diagnosis and Treatment Overview 57
5.1.1 Diagnosis 57
5.1.2 Treatment Guidelines and Leading Prescribed Drugs 59
5.1.3 Clinical Practice 62
5.2 US 64
5.3 France 66
5.4 Germany 68
5.5 Italy 70
5.6 Spain 72
5.7 UK 74
5.8 Japan 76
6 Competitive Assessment 78
6.1 Overview 78
6.2 Product Profiles – Major Brands, IBS-C 79
6.2.1 Amitiza (lubiprostone) 79
6.2.2 Linzess (linaclotide) 85
6.3 Product Profiles – Major Brands, IBS-D 93
6.3.1 Lotronex (alosetron) 93
6.3.2 Irribow (ramosetron) 98
6.4 Product Profiles – Major Brands, Other 103
6.4.1 Antidepressants 103
6.5 Other Therapeutic Classes 108
7 Unmet Need and Opportunity 110
7.1 Overview 110
7.2 More Effective Pharmacotherapies 111
7.2.1 Unmet Need 111
7.2.2 Gap Analysis 112
7.2.3 Opportunity 113
7.3 Therapies for the IBS-D Subtype 113
7.3.1 Unmet Need 113
7.3.2 Gap Analysis 114
7.3.3 Opportunity 114
7.4 Therapies for the IBS-M Subtype 114
7.4.1 Unmet Need 114
7.4.2 Gap Analysis 115
7.4.3 Opportunity 115
7.5 Therapies to Address Abdominal Pain and Bloating Symptoms 115
7.5.1 Unmet Need 115
7.5.2 Gap Analysis 116
7.5.3 Opportunity 116
7.6 Improved Diagnosis Rate for IBS 117
7.6.1 Unmet Need 117
7.6.2 Gap Analysis 117
7.6.3 Opportunity 117
8 Pipeline Assessment 119
8.1 Overview 119
8.2 Clinical Trial Mapping 119
8.2.1 Clinical Trials by Therapy Type 119
8.3 Promising Drugs in Clinical Development 120
8.4 Product Profiles – Late-Stage Pipeline, IBS-D 123
8.4.1 Eluxadoline 123
8.4.2 Ibodutant (MEN-15596) 130
8.4.3 Xifaxan (rifaximin) 136
8.5 Product Profiles – Late-Stage Pipeline, IBS-C 145
8.5.1 Plecanatide 145
8.5.2 Tenapanor (AZD1722, RDX5791) 151
8.6 Other Drugs in Development for IBS 156
9 Current and Future Players 157
9.1 Overview 157
9.2 Trends in Corporate Strategy 159
9.3 Company Profiles 160
9.3.1 Actavis 160
9.3.2 Astellas 162
9.3.3 Almirall 165
9.3.4 Ironwood 166
9.3.5 Takeda 169
9.3.6 Sucampo 171
9.3.7 Prometheus 173
9.3.8 Salix 175
9.3.9 Menarini 177
9.3.10 Synergy 179
9.3.11 AstraZeneca 181
10 Market Outlook 183
10.1 Global Markets 183
10.1.1 Forecast 183
10.1.2 Drivers and Barriers – Global Issues 187
10.2 US 188
10.2.1 Forecast 188
10.2.2 Key Events 192
10.2.3 Drivers and Barriers 192
10.3 France 194
10.3.1 Forecast 194
10.3.2 Key Events 198
10.3.3 Drivers and Barriers 198
10.4 Germany 200
10.4.1 Forecast 200
10.4.2 Key Events 204
10.4.3 Drivers and Barriers 204
10.5 Italy 206
10.5.1 Forecast 206
10.5.2 Key Events 210
10.5.3 Drivers and Barriers 210
10.6 Spain 212
10.6.1 Forecast 212
10.6.2 Key Events 215
10.6.3 Drivers and Barriers 215
10.7 UK 217
10.7.1 Forecast 217
10.7.2 Key Events 221
10.7.3 Drivers and Barriers 221
10.8 Japan 223
10.8.1 Forecast 223
10.8.2 Key Events 227
10.8.3 Drivers and Barriers 227
11 Appendix 230
11.1 Bibliography 230
11.2 Abbreviations 240
11.3 Methodology 243
11.4 Forecasting Methodology 243
11.4.1 Diagnosed IBS Patients 243
11.4.2 Drugs Included in Each Therapy Type 244
11.4.3 Launch and Patent Expiry Dates 244
11.4.4 General Pricing Assumptions 245
11.4.5 Individual Drug Assumptions 246
11.4.6 Generic Erosion 247
11.4.7 Pricing of Pipeline Agents 247
11.5 Primary Research – KOLs Interviewed for This Report 248
11.6 Primary Research – Prescriber Survey 250
11.7 About the Authors 251
11.7.1 Analyst 251
11.7.2 Therapy Area Director 251
11.7.3 Epidemiologist 252
11.7.4 Global Head of Healthcare 253
11.8 About GlobalData 254
11.9 Disclaimer 254
【レポート販売概要】
■ タイトル：過敏性腸症候群（Irritable Bowel Syndrome）治療薬の世界市場予測および分析■ 英文：PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023
■ 発行日：2014年12月31日
■ 調査会社：GlobalData
■ 商品コード：GDHC97PIDR
■ 調査対象地域：グローバル
- 自動車用マルチメディアタッチパッドの世界市場2018-2022109 pages, November 2018 About this market The global automotive market is observing an increase in proliferation of infotainment systems following the introduction of touchscreen interfaces. Touchscreens are easy to operate and are familiar to customers from their deployment in smartphones. These factors have made touchscreens important for the success of infotainment systems in modern vehicles. …
- トロポニンIの世界市場Troponin I (CAS 77108-40-8) Market Research Report 2013 presents comprehensive data on troponin I markets globally and regionally (Europe, Asia, North America etc.) The Troponin I (CAS 77108-40-8) Market Research Report 2013 includes troponin I description, covers its application areas and related patterns. It overviews troponin I market, names troponin I producers and indicates its suppliers. Bes …
- 非黒色腫皮膚がん治療のグローバル市場（2014-2018）About Non-melanoma Skin Cancer Non-melanoma skin cancer is one of the most common types of cancer in the world. It develops in the upper layers of the skin, but not in melanocytes. There are two types of non-melanoma skin cancer: BCC, which starts in the basal cells, and SCC, which starts in the squamous cells. BCC usually develops in the areas such as the head and neck, whereas SCC starts in the …
- グローバル製薬市場におけるトップ10企業分析Synopsis The ICD Research Global Top 10 Pharmaceutical Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global pharmaceutical industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. Johnson & Johnson Pfizer Inc. Novartis AG …
- 自動車用可変容量ターボチャージャー（VGT）の世界市場About Automotive VGT An automotive turbocharger is a component that helps the engine to produce additional power and improves the overall performance of the vehicle. The turbocharger has two components: turbine and compressor. It uses the exhaust air that is released after fuel and air combustion in a vehicle combustion chamber. When this exhaust air strikes the turbine blades, it causes the turbi …
- エンドウ豆タンパクの世界市場2016-2020About the Pea Protein Market Pea protein is extracted from yellow peas, known as Pisum sativum, and has a typical legume amino acid profile. Being highly nutritive and functional, pea protein has gained a strong foothold in the plant-based protein market. It is also a clean-label product with non-allergic attributes and is a viable alternative to eggs and is therefore used in a variety of bakery a …
- 保護用作業服の世界市場About Protective WorkwearOne of the prominent categories of the personal protective clothing is protective workwear or protective clothing. This is protective or safety apparel that is worn by workers for protection against various thermal, chemical, mechanical, and biological hazards. Such clothing is usually made of aramid and blends, polyolefins and blends, polyamides, polybenzimidazole (PBI), …
- ミックスドシグナルSoC（システムオンチップ）の世界市場About mixed signal SoC A mixed signal SoC is an electronic circuit that integrates both analog circuits and digital circuits on a single semiconductor die. It is an IC consisting of a large number of transistors on a single chip with applications in embedded systems. Most of the electronic systems accommodate analog signals because of the applicability of analog interfaces in many systems such as …
- 紙用顔料の世界市場2019-2023102 pages, November 2018 About this market Increasing adoption of UWF paper in packaging to gain traction in the global paper pigments market. The advent of industry 4.0 has led to technological advances and increased adoption of sustainable packaging solutions. Technavio’s analysts have predicted that the Paper Pigments market will register a CAGR of around 4% by 2023. Market Overview Growing con …
- 副腎皮質癌治療薬の世界市場：化学療法、標的療法Global Adrenocortical Carcinoma Drugs Market: About this market Adrenocortical carcinoma drugs significantly include chemotherapeutics. Technavio’s adrenocortical carcinoma drugs market analysis considers sales from chemotherapy and targeted therapy segments. Our analysis also considers the sales of adrenocortical carcinoma drugs Asia, Europe, North America, and ROW. In 2018, the chemotherapy segm …
- スキンパッケージの世界市場2017-2021About Skin PackagingGlobal skin packaging market is classified into two types: Carded and non-carded. Carded skin packaging consists of a piece of paperboard and a thin sheet of transparent plastic heat sealing, which is wrapped over the paperboard. The product is placed between them during the packaging process. Non-carded skin packaging consists of a thin sheet of plastic wrapped over the produc …
- オピオイド誘発性腸機能障害：グローバル臨床試験レビュー（2014年上半期）Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014" provides data on the Opioid Induced Bowel Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Opioid Induced Bowel Dysfunction. It inclu …
- アルミカーテンウォールの世界市場：製品別（現場組立式、半ユニット式、ユニット式）、用途別（商業用、住宅用）、地域別、セグメント予測The global aluminum curtain wall market size is expected to reach USD 54.38 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 9.3% during the forecast period. The need to protect exterior walls coupled with the upsurge in the construction of commercial buildings, including offices and institutions, in developed and developing economies i …
- 世界の燃料電池市場展望（～2018）The fuel cell industry, which is presently on a nascent stage, presents huge potential for growth in the coming years. Its efficiency created demand for the technology in various application areas including military, electronic devices, transportation, traffic signaling, security and remote monitoring, etc. Also, declining prices of fuel cells and advanced R&D activities are adding growth to the f …
- 黄斑変性症（AMD）及びその他の網膜疾患治療薬の世界市場AMD and Other Retinal Diseases – our new study reveals trends, R&D progress, and predicted revenuesWhere is the AMD and Other Retinal Diseases market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2026, assessing data, trends, opportunities and business prospects there. Discover How to Stay Ahead Our …
